Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T cell-oriented strategies for controlling the COVID-19 pandemic
Ji Yun Noh, Hye Won Jeong, Jérôme H. Kim, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 687-688
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 133
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
Stephen J. Kent, David S. Khoury, Arnold Reynaldi, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 6, pp. 387-397
Open Access | Times Cited: 119
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
Seong Jin Choi, Dong-Uk Kim, Ji Yun Noh, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 447-448
Open Access | Times Cited: 94
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid Ahmad Sheikh, Neha Quadir, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210264-210264
Open Access | Times Cited: 71
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55
Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells
Marco Künzli, Stephen O’Flanagan, Madeleine LaRue, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 49
Assessing the generation of tissue resident memory T cells by vaccines
E. Rotrosen, Thomas S. Kupper
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 655-665
Open Access | Times Cited: 33
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity
Jonathan J. Park, Kyoung A Lee, Stanley Z. Lam, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 21
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
Iris N. Pardieck, Tetje C. van der Sluis, Esmé T.I. van der Gracht, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort
Pablo Barreiro, Juan Carlos Sanz, Jesús San Román, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 3
Open Access | Times Cited: 35
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 35
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Zsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 539-539
Open Access | Times Cited: 32
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
Christine E Nelson, Sivaranjani Namasivayam, Taylor W. Foreman, et al.
Science Immunology (2022) Vol. 7, Iss. 70
Open Access | Times Cited: 30
Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
Endeshaw Chekol Abebe, Markeshaw Tiruneh G Medhin, Awgichew Behaile T Mariam, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 1871-1887
Open Access | Times Cited: 30
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 335-346
Open Access | Times Cited: 28
A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population
Grace J. Kim, Jacob H. Elnaggar, Mallory Varnado, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Omicron BA.2 breakthrough infection elicits CD8 + T cell responses recognizing the spike of later Omicron subvariants
Sang-Hoon Kim, Jihye Kim, Sungmin Jung, et al.
Science Immunology (2024) Vol. 9, Iss. 91
Closed Access | Times Cited: 5
Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here
Daniel T. Halperin, Norman Hearst, Stephen Hodgins, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
Hye Won Jeong, Se‐Mi Kim, Min Kyung Jung, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100764-100764
Open Access | Times Cited: 26
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 13
Immunosequencing and epitope mapping reveal substantial preservation of the T cell immune response to Omicron generated by SARS-CoV-2 vaccines
Damon May, Benjamin E. Rubin, Sudeb C. Dalai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 27
Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines
Elham Jamshidi, Amirhossein Asgary, Paria Shafiekhani, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top